首页> 外国专利> PHARMACEUTICAL COMPOSITION HAVING ANGIOTENSIN II ANTAGONISTIC ACTIVITY OR SALT THEREOF WITH AN INSULIN-SENSITIVITY INCREASING COMPOUND AND POSTPRANDIAL HYPERGLYCEMIA IN DIABETES MELLITUS AND ANTAGONISTIC ACTIVITY AND INCREASED INSULIN-SENSITIVITY

PHARMACEUTICAL COMPOSITION HAVING ANGIOTENSIN II ANTAGONISTIC ACTIVITY OR SALT THEREOF WITH AN INSULIN-SENSITIVITY INCREASING COMPOUND AND POSTPRANDIAL HYPERGLYCEMIA IN DIABETES MELLITUS AND ANTAGONISTIC ACTIVITY AND INCREASED INSULIN-SENSITIVITY

机译:具有血管紧张素II拮抗活性或其盐的药物组合物,其胰岛素敏感性增加了糖尿病患者的复合和餐后高血糖症,并且拮抗活性和胰岛素敏感性增强

摘要

To provide a pharmaceutical composition which performs a remarkable effect with a relatively decreased dosage, and, with less side effects, a pharmaceutical composition formulated by combination of an angiotensin II-mediated compound or a salt thereof with at least one species of a compound having the activity of increasing insulin-sensitivity, a compound having the activity of improving postprandial hyperglycemia in diabetes mellitus, an indane derivative having the activity of inhibiting angiotensin converting enzyme, a pyridine derivative having the activity of inhibiting HMG-Co A reductase or salts thereof are advantageously employed.
机译:为了提供一种药物组合物,该药物组合物通过将血管紧张素II介导的化合物或其盐与至少一种具有以下特征的化合物组合而配制,该药物组合物以相对降低的剂量表现出显着的效果,并且副作用较少。具有提高胰岛素敏感性的活性,具有改善糖尿病的餐后高血糖活性的化合物,具有抑制血管紧张素转化酶活性的茚满衍生物,具有抑制HMG-Co A还原酶活性的吡啶衍生物或其盐是有利的。受雇。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号